Sviluppa tessuti umani biofabbricati e modelli organoidi come alternativa ai test su animali per pharma e cosmetica.
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Funding round Biodimension raised ₹8 Cr (~$0.9M) in a round led by IAN Angel Fund for product development and lab infrastructure. | $920K |